Global Cord Blood Corporation Stock price
Equities
CORBF
KYG393421030
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | 0.00% | 0.00% | +10.66% |
Sep. 29 | Global Cord Blood Corporation Announces Board Appointments | CI |
Mar. 20 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M | Sales 2022 | 1.24B 172M | Capitalization | 2.97B 411M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.3M | Net income 2022 | 501M 69.33M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 841M | Net cash position 2022 | 6.66B 922M | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Current month | -10.00% | ||
1 month | -10.00% | ||
3 months | -6.90% | ||
6 months | +8.87% | ||
Current year | +10.66% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.35 | 0.00% | 8,503 |
24-03-27 | 1.35 | 0.00% | 402 |
24-03-25 | 1.35 | -10.00% | 4,372 |
24-03-22 | 1.5 | +11.11% | 681 |
24-03-20 | 1.35 | -10.00% | 130 |
Delayed Quote OTC Markets, March 28, 2024 at 01:55 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+10.66% | 181M | |
+1.01% | 99.96B | |
+23.22% | 87.73B | |
+10.42% | 29.33B | |
-3.88% | 18.21B | |
-3.46% | 14.51B | |
+19.69% | 12.22B | |
+31.78% | 12B | |
+0.17% | 11.94B | |
-12.00% | 11.63B |